InsiderTrades.com logo

ONCO Insider Trading

Insider Ownership Percentage: 0.27%
Insider Buying (Last 12 Months): $127,590.54
Insider Selling (Last 12 Months): $0.00

Onconetix Insider Trading History Chart

This chart shows the insider buying and selling history at Onconetix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Onconetix Share Price & Price History

Current Price: $0.76
Price Change: ▼ Price Decrease of -0.0015 (-0.20%)
As of 04/16/2026 05:00 PM ET

This chart shows the closing price history over time for ONCO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Onconetix Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/15/2026Financial Lp HrtMajor ShareholderBuy92,554$0.76$70,341.04197,052View SEC Filing Icon  
4/14/2026Financial Lp HrtMajor ShareholderBuy74,350$0.77$57,249.50104,498View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Onconetix (NASDAQ:ONCO)

23.89% of Onconetix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ONCO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Onconetix Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/12/2026DRW Securities LLC39,046$61K0.0%-36.8%2.519%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC15,633$49K0.0%N/A1.002%Search for SEC Filing on Google Icon
10/29/2025Pacific Capital Wealth Advisors Inc.13,000$40K0.0%N/A0.839%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC39,477$25K0.0%N/A0.476%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC55,418$35K0.0%N/A0.668%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank 562,691$2.93M0.0%+83.8%76.039%Search for SEC Filing on Google Icon
7/29/2024Zurcher Kantonalbank Zurich Cantonalbank306,079$51K0.0%N/A1.371%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Onconetix logo
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
Read More on Onconetix

Today's Range

Now: $0.76
Low: $0.69
High: $0.78

50 Day Range

MA: $3.07
Low: $0.76
High: $9.25

52 Week Range

Now: $0.76
Low: $0.67
High: $74.29

Volume

1,952,362 shs

Average Volume

4,884,322 shs

Market Capitalization

$501.60 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.63

Who are the company insiders with the largest holdings of Onconetix?

Onconetix's top insider shareholders include:
  1. Financial Lp Hrt (Major Shareholder)
Learn More about top insider investors at Onconetix.